Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease ; volume:13 ; number:1 ; day:17 ; month:2 ; year:2021 ; pages:1-12 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (17.2.2021), 1-12, 12.2021
- Creator
-
Grau-Rivera, Oriol
Navalpotro-Gomez, Irene
Sánchez-Benavides, Gonzalo
Suárez-Calvet, Marc
Milà-Alomà, Marta
Arenaza-Urquijo, Eider M.
Salvadó, Gemma
Sala-Vila, Aleix
Shekari, Mahnaz
González-de-Echávarri, José Maria
Minguillón, Carolina
Niñerola-Baizán, Aida
Perissinotti, Andrés
Simon, Maryline
Kollmorgen, Gwendlyn
Zetterberg, Henrik
Blennow, Kaj
Gispert, Juan D.
Molinuevo, José Luis
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00781-z
- URN
-
urn:nbn:de:101:1-2021040623263884004980
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grau-Rivera, Oriol
- Navalpotro-Gomez, Irene
- Sánchez-Benavides, Gonzalo
- Suárez-Calvet, Marc
- Milà-Alomà, Marta
- Arenaza-Urquijo, Eider M.
- Salvadó, Gemma
- Sala-Vila, Aleix
- Shekari, Mahnaz
- González-de-Echávarri, José Maria
- Minguillón, Carolina
- Niñerola-Baizán, Aida
- Perissinotti, Andrés
- Simon, Maryline
- Kollmorgen, Gwendlyn
- Zetterberg, Henrik
- Blennow, Kaj
- Gispert, Juan D.
- Molinuevo, José Luis
- SpringerLink (Online service)
Other Objects (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Levels of ADAM10 are reduced in Alzheimer’s disease CSF